Large-scale foreign investments in pharmaceuticals may be coming to an end

According to the Polish Agency for Foreign Investment (PAIZ) western c ompanies have pumped $587.5 million into the Polish pharmaceutical industry. However Poland cannot count on further large investments as the number of available plants up for sale is limited, and the remaining state-owned pharmaceutical factories will be merged into a group controlled by the Treasury Ministry. The largest investor in this field is GlaxoSmithKline, which acquired the Poznan-based Polfa from the Treasury and which already controls 7% of the domestic market. (Puls Biznesu, p. 8) A.K.